Clinical Trial Update: Effect of the Inhibitors of the Way JAK-STAT on Regulatory B Cells [NA]

View source ↗

Summary

A clinical trial assessing the effect of JAK-STAT inhibitors on regulatory B cells in rheumatoid arthritis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Rheumatoid Arthritis | NA | Status: TERMINATED